Search
  • Within this site
AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Back to search results

Cell Encapsulation on a Microfluidic Platform


Technology Application

The present invention can be used in cell culture applications for isolating and distributing small groups of cells for further culturing. Single cell droplets can be replated at clonal density and processed in an automated and complex fashion, while multiple cell droplets can be fused and cultured to produce cell populations from precisely defined, heterogeneous initial conditions. For cell assay applications, cell droplets can be used for sorting similar to fluorescence-activated cell sorting (FACS) on a much smaller, precise, and less expensive platform. The invention can be further utilized in cell-based therapies to encapsulate stem cells or other regenerative cells in polymerized capsules, serving as an improvement over existing encapsulation-based therapies by providing smaller capsule size, improved structural properties, more uniform mixing and reaction times, and the possibility of incorporating further microfluidic processing upstream and downstream of the encapsulation area.


Detailed Technology Description

Univeristy of California researchers have developed a novel microfluidic platform for encapsulation of cells in droplets. Cells can be loaded at low or high densities to achieve droplets of 1-5 cells or up to 20-50 cells. Droplet size can be manipulated by channel geometries and flow rates. In contrast with prior batch techniques, this device allows for a smaller minimum droplet size of 100 ?m or less and droplet trapping before or without polymerization. The continuous nature of the encapsulation process successfully achieves mono-dispersity of droplet size and uniform polymerization times across the droplet population. The platform also allows flexibility in creating tailored local environments, combinatorial biochemistry, or heterogeneous cell populations to enhance cell differentiation or proliferation. The method also provides for both permanent and temporary encapsulation by forming either a polymerized capsule or a simple, immiscible fluid separation, respectively.


Supplementary Information

Patent Number: US7759111B2
Application Number: US2005215352A
Inventor: Lee, Abraham Phillip | Fisher, Jeffrey S.
Priority Date: 27 Aug 2004
Priority Number: US7759111B2
Application Date: 29 Aug 2005
Publication Date: 20 Jul 2010
IPC Current: C12M000100 | C12N001104
US Class: 4352831 | 435182
Assignee Applicant: The Regents of the University of California
Title: Cell encapsulation microfluidic device
Usefulness: Cell encapsulation microfluidic device
Summary: The microfluidic device is useful for encapsulating cells into a droplet and can provide a polymer bead round the droplet (claimed). Through droplet fusion, the cells can be rapidly, combinatorially exposed to various drugs or chemical factors. The droplets can be used for automating clonal culturing, and droplets containing different types of cells can be fused to form well-defined, heterogeneous populations.
Novelty: New microfluidic device comprising a first region comprising a cell loading zone and a shearing zone or a second region downstream of the first region comprising a cell encapsulation zone, useful for encapsulating cells


Industry

Biomedical


Sub Group

Medical Device


Application No.

7759111


Others

Tech ID/UC Case

18839/2004-547-0


Related Cases

2004-547-0


Country/Region

USA

For more information, please click Here
Business of IP Asia Forum
Desktop View